Exercise may be key to developing treatments for rare movement disorder

exercise
Credit: Pixabay/CC0 Public Domain

Spinal cerebellar ataxia 6 (SCA6) is an inherited neurological condition which has a debilitating impact on motor coordination. Affecting around 1 in 100,000 people, the rarity of SCA6 has seen it attract only limited attention from medical researchers. To date, there is no known cure and only limited treatment options exist.

Now, a team of McGill University researchers specializing in SCA6 and other forms of ataxia, have published findings that not only offer hope for SCA6 sufferers but may also open the way to developing treatments for other .

Exercise in a pill

In mice affected by SCA6, the McGill team, led by biology professor Alanna Watt, found that exercise restored the health of cells in the cerebellum, the part of the brain implicated in SCA6 and other ataxias. The reason for the improvement, the researchers found, was that exercise increased levels of brain-derived (BDNF), a naturally occurring substance in the brain which supports the growth and development of nerve cells. Importantly for patients with a , for whom exercise may not always be feasible, the team demonstrated that a drug that mimicked the action of BDNF could work just as well as exercise, if not better.

Early intervention crucial

The researchers also discovered that BDNF levels in SCA6 mice declined well before movement difficulties began to appear. The drug, they found, worked to arrest the decline only if it was given before the onset of outwardly visible symptoms.

“That’s not something we really knew about SCA6,” said lead author Anna Cook, a Ph.D. candidate in Professor Watt’s lab. “If there are these early changes in the brain that people don’t even know about, it tends to advocate for more genetic screening and early intervention for these rare diseases.”



More information: Anna A. Cook et al, Activation of TrkB-Akt signaling rescues deficits in a mouse model of SCA6, Science Advances (2022). DOI: 10.1126/sciadv.abh3260

Citation: Exercise may be key to developing treatments for rare movement disorder (2022, September 17) retrieved 13 October 2022 from https://medicalxpress.com/news/2022-09-key-treatments-rare-movement-disorder.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Vaccine credentials enabling wider progress on public health interoperability thumbnail

Vaccine credentials enabling wider progress on public health interoperability

First announced in January 2021, the Vaccine Credential Initiative – co-founded by MITRE Corporation and others including Cerner, Change Healthcare, Epic, Mayo Clinic, Microsoft, Oracle, Salesforce and others – has made big progress over the past year-plus on new approaches to interoperable record-keeping. The public and private partnership collaborated on developing a standard model for…
Read More
Health Experts Ask PTMs to be Evaluated The Impact of the Emergence of School Clusters thumbnail

Health Experts Ask PTMs to be Evaluated The Impact of the Emergence of School Clusters

BEBERAPA wilayah level 1-3 yang telah melakukan pembelajaran tatap muka (PTM), melaporkan munculnya klaster baru Covid-19 yang terjadi pada siswa. Ribuan siswa dari berbagai wilayah di Indonesia menjadi imbas dari diberlakukannya kembali PTM. Tentunya kondisi ini menjadi dilema tersendiri bagi masyarakat dan juga pemerintah. Sebab saat ini pemerintah berupaya untuk terus menurunkan angka penularan Covid-19.…
Read More
Letter to the Editor: ‘Dirty Dozen’ requires a second look thumbnail

Letter to the Editor: ‘Dirty Dozen’ requires a second look

Dear Editor, I saw your story regarding the “Dirty Dozen” list and would appreciate your consideration of updating your content to include some additional facts and information for your readers so there is a balanced perspective and inclusive of peer reviewed studies, not just claims from Environmental Working Group. Peer reviewed research published in the Journal
Read More
Precision Medicine Approach Shows Promise for Anaplastic Thyroid Cancer thumbnail

Precision Medicine Approach Shows Promise for Anaplastic Thyroid Cancer

Oncology/Hematology > Other Cancers — Median OS as high as 43 months with mutation-guided targeted agents plus immunotherapy by Charles Bankhead, Senior Editor, MedPage Today October 25, 2024 Two prospective trials of immunotherapy in thyroid cancer, one of them negative, provided support for precision-medicine approaches that include immunotherapy. A trial of atezolizumab (Tecentriq) and mutation-selected
Read More
Index Of News